nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Instillation site pain—Imiquimod—skin cancer	0.0672	0.0672	CcSEcCtD
Gadobutrol—Application site pain—Imiquimod—skin cancer	0.0498	0.0498	CcSEcCtD
Gadobutrol—Pregnancy—Imiquimod—skin cancer	0.0386	0.0386	CcSEcCtD
Gadobutrol—Application site pain—Fluorouracil—skin cancer	0.0275	0.0275	CcSEcCtD
Gadobutrol—Parosmia—Temozolomide—skin cancer	0.0202	0.0202	CcSEcCtD
Gadobutrol—Aphasia—Temozolomide—skin cancer	0.0202	0.0202	CcSEcCtD
Gadobutrol—Apathy—Temozolomide—skin cancer	0.0184	0.0184	CcSEcCtD
Gadobutrol—Flat affect—Temozolomide—skin cancer	0.0182	0.0182	CcSEcCtD
Gadobutrol—Dysgeusia—Vismodegib—skin cancer	0.0178	0.0178	CcSEcCtD
Gadobutrol—Parosmia—Docetaxel—skin cancer	0.0135	0.0135	CcSEcCtD
Gadobutrol—Sweating increased—Imiquimod—skin cancer	0.0134	0.0134	CcSEcCtD
Gadobutrol—Pain—Vismodegib—skin cancer	0.0127	0.0127	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vismodegib—skin cancer	0.0121	0.0121	CcSEcCtD
Gadobutrol—Abdominal pain—Vismodegib—skin cancer	0.0117	0.0117	CcSEcCtD
Gadobutrol—Abnormal vision—Temozolomide—skin cancer	0.0114	0.0114	CcSEcCtD
Gadobutrol—Dysgeusia—Vemurafenib—skin cancer	0.011	0.011	CcSEcCtD
Gadobutrol—Visual impairment—Imiquimod—skin cancer	0.0106	0.0106	CcSEcCtD
Gadobutrol—Hot flush—Temozolomide—skin cancer	0.0102	0.0102	CcSEcCtD
Gadobutrol—Diarrhoea—Vismodegib—skin cancer	0.0101	0.0101	CcSEcCtD
Gadobutrol—Menopausal symptoms—Temozolomide—skin cancer	0.0101	0.0101	CcSEcCtD
Gadobutrol—Vomiting—Vismodegib—skin cancer	0.00943	0.00943	CcSEcCtD
Gadobutrol—Rash—Vismodegib—skin cancer	0.00935	0.00935	CcSEcCtD
Gadobutrol—Dermatitis—Vismodegib—skin cancer	0.00934	0.00934	CcSEcCtD
Gadobutrol—Anaphylactic shock—Vemurafenib—skin cancer	0.00916	0.00916	CcSEcCtD
Gadobutrol—Infection—Vemurafenib—skin cancer	0.0091	0.0091	CcSEcCtD
Gadobutrol—Nausea—Vismodegib—skin cancer	0.00881	0.00881	CcSEcCtD
Gadobutrol—Palpitations—Imiquimod—skin cancer	0.00846	0.00846	CcSEcCtD
Gadobutrol—Convulsion—Imiquimod—skin cancer	0.0083	0.0083	CcSEcCtD
Gadobutrol—Sweating increased—Temozolomide—skin cancer	0.00802	0.00802	CcSEcCtD
Gadobutrol—Dry mouth—Imiquimod—skin cancer	0.00797	0.00797	CcSEcCtD
Gadobutrol—Hypoaesthesia—Bleomycin—skin cancer	0.00778	0.00778	CcSEcCtD
Gadobutrol—Infection—Imiquimod—skin cancer	0.00776	0.00776	CcSEcCtD
Gadobutrol—Pollakiuria—Temozolomide—skin cancer	0.00761	0.00761	CcSEcCtD
Gadobutrol—Hyperhidrosis—Imiquimod—skin cancer	0.00756	0.00756	CcSEcCtD
Gadobutrol—Body temperature increased—Vemurafenib—skin cancer	0.00724	0.00724	CcSEcCtD
Gadobutrol—Insomnia—Imiquimod—skin cancer	0.00707	0.00707	CcSEcCtD
Gadobutrol—Paraesthesia—Imiquimod—skin cancer	0.00702	0.00702	CcSEcCtD
Gadobutrol—Dyspnoea—Imiquimod—skin cancer	0.00697	0.00697	CcSEcCtD
Gadobutrol—Hot flush—Docetaxel—skin cancer	0.00677	0.00677	CcSEcCtD
Gadobutrol—Hypersensitivity—Vemurafenib—skin cancer	0.00675	0.00675	CcSEcCtD
Gadobutrol—Menopausal symptoms—Docetaxel—skin cancer	0.00672	0.00672	CcSEcCtD
Gadobutrol—Pain—Imiquimod—skin cancer	0.00668	0.00668	CcSEcCtD
Gadobutrol—Hypoaesthesia—Temozolomide—skin cancer	0.00656	0.00656	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Imiquimod—skin cancer	0.00639	0.00639	CcSEcCtD
Gadobutrol—Visual impairment—Temozolomide—skin cancer	0.00635	0.00635	CcSEcCtD
Gadobutrol—Diarrhoea—Vemurafenib—skin cancer	0.00627	0.00627	CcSEcCtD
Gadobutrol—Abdominal pain—Imiquimod—skin cancer	0.00618	0.00618	CcSEcCtD
Gadobutrol—Body temperature increased—Imiquimod—skin cancer	0.00618	0.00618	CcSEcCtD
Gadobutrol—Dizziness—Vemurafenib—skin cancer	0.00606	0.00606	CcSEcCtD
Gadobutrol—Hypoaesthesia—Fluorouracil—skin cancer	0.00604	0.00604	CcSEcCtD
Gadobutrol—Vomiting—Vemurafenib—skin cancer	0.00583	0.00583	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Docetaxel—skin cancer	0.00579	0.00579	CcSEcCtD
Gadobutrol—Rash—Vemurafenib—skin cancer	0.00578	0.00578	CcSEcCtD
Gadobutrol—Dermatitis—Vemurafenib—skin cancer	0.00577	0.00577	CcSEcCtD
Gadobutrol—Hypersensitivity—Imiquimod—skin cancer	0.00576	0.00576	CcSEcCtD
Gadobutrol—Headache—Vemurafenib—skin cancer	0.00574	0.00574	CcSEcCtD
Gadobutrol—Dysgeusia—Temozolomide—skin cancer	0.00562	0.00562	CcSEcCtD
Gadobutrol—Anaphylactic shock—Bleomycin—skin cancer	0.00555	0.00555	CcSEcCtD
Gadobutrol—Infection—Bleomycin—skin cancer	0.00552	0.00552	CcSEcCtD
Gadobutrol—Nausea—Vemurafenib—skin cancer	0.00544	0.00544	CcSEcCtD
Gadobutrol—Diarrhoea—Imiquimod—skin cancer	0.00535	0.00535	CcSEcCtD
Gadobutrol—Dizziness—Imiquimod—skin cancer	0.00517	0.00517	CcSEcCtD
Gadobutrol—Vertigo—Temozolomide—skin cancer	0.00516	0.00516	CcSEcCtD
Gadobutrol—Infection—Dactinomycin—skin cancer	0.00514	0.00514	CcSEcCtD
Gadobutrol—Palpitations—Temozolomide—skin cancer	0.00507	0.00507	CcSEcCtD
Gadobutrol—Paraesthesia—Bleomycin—skin cancer	0.00499	0.00499	CcSEcCtD
Gadobutrol—Convulsion—Temozolomide—skin cancer	0.00497	0.00497	CcSEcCtD
Gadobutrol—Vomiting—Imiquimod—skin cancer	0.00497	0.00497	CcSEcCtD
Gadobutrol—Dyspnoea—Bleomycin—skin cancer	0.00495	0.00495	CcSEcCtD
Gadobutrol—Rash—Imiquimod—skin cancer	0.00493	0.00493	CcSEcCtD
Gadobutrol—Dermatitis—Imiquimod—skin cancer	0.00492	0.00492	CcSEcCtD
Gadobutrol—Headache—Imiquimod—skin cancer	0.0049	0.0049	CcSEcCtD
Gadobutrol—Dry mouth—Temozolomide—skin cancer	0.00478	0.00478	CcSEcCtD
Gadobutrol—Pain—Bleomycin—skin cancer	0.00475	0.00475	CcSEcCtD
Gadobutrol—Anaphylactic shock—Temozolomide—skin cancer	0.00468	0.00468	CcSEcCtD
Gadobutrol—Infection—Temozolomide—skin cancer	0.00465	0.00465	CcSEcCtD
Gadobutrol—Nausea—Imiquimod—skin cancer	0.00464	0.00464	CcSEcCtD
Gadobutrol—Convulsion—Fluorouracil—skin cancer	0.00458	0.00458	CcSEcCtD
Gadobutrol—Hyperhidrosis—Temozolomide—skin cancer	0.00453	0.00453	CcSEcCtD
Gadobutrol—Pain—Dactinomycin—skin cancer	0.00443	0.00443	CcSEcCtD
Gadobutrol—Body temperature increased—Bleomycin—skin cancer	0.00439	0.00439	CcSEcCtD
Gadobutrol—Hypoaesthesia—Docetaxel—skin cancer	0.00436	0.00436	CcSEcCtD
Gadobutrol—Anaphylactic shock—Fluorouracil—skin cancer	0.00432	0.00432	CcSEcCtD
Gadobutrol—Infection—Fluorouracil—skin cancer	0.00429	0.00429	CcSEcCtD
Gadobutrol—Insomnia—Temozolomide—skin cancer	0.00424	0.00424	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dactinomycin—skin cancer	0.00423	0.00423	CcSEcCtD
Gadobutrol—Visual impairment—Docetaxel—skin cancer	0.00423	0.00423	CcSEcCtD
Gadobutrol—Paraesthesia—Temozolomide—skin cancer	0.00421	0.00421	CcSEcCtD
Gadobutrol—Dyspnoea—Temozolomide—skin cancer	0.00418	0.00418	CcSEcCtD
Gadobutrol—Body temperature increased—Dactinomycin—skin cancer	0.00409	0.00409	CcSEcCtD
Gadobutrol—Abdominal pain—Dactinomycin—skin cancer	0.00409	0.00409	CcSEcCtD
Gadobutrol—Hypersensitivity—Bleomycin—skin cancer	0.00409	0.00409	CcSEcCtD
Gadobutrol—Pain—Temozolomide—skin cancer	0.00401	0.00401	CcSEcCtD
Gadobutrol—Insomnia—Fluorouracil—skin cancer	0.0039	0.0039	CcSEcCtD
Gadobutrol—Paraesthesia—Fluorouracil—skin cancer	0.00388	0.00388	CcSEcCtD
Gadobutrol—Dyspnoea—Fluorouracil—skin cancer	0.00385	0.00385	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Temozolomide—skin cancer	0.00383	0.00383	CcSEcCtD
Gadobutrol—Hypersensitivity—Dactinomycin—skin cancer	0.00382	0.00382	CcSEcCtD
Gadobutrol—Dysgeusia—Docetaxel—skin cancer	0.00374	0.00374	CcSEcCtD
Gadobutrol—Abdominal pain—Temozolomide—skin cancer	0.0037	0.0037	CcSEcCtD
Gadobutrol—Body temperature increased—Temozolomide—skin cancer	0.0037	0.0037	CcSEcCtD
Gadobutrol—Pain—Fluorouracil—skin cancer	0.00369	0.00369	CcSEcCtD
Gadobutrol—Diarrhoea—Dactinomycin—skin cancer	0.00354	0.00354	CcSEcCtD
Gadobutrol—Vomiting—Bleomycin—skin cancer	0.00353	0.00353	CcSEcCtD
Gadobutrol—Rash—Bleomycin—skin cancer	0.0035	0.0035	CcSEcCtD
Gadobutrol—Dermatitis—Bleomycin—skin cancer	0.0035	0.0035	CcSEcCtD
Gadobutrol—Hypersensitivity—Temozolomide—skin cancer	0.00345	0.00345	CcSEcCtD
Gadobutrol—Body temperature increased—Fluorouracil—skin cancer	0.00341	0.00341	CcSEcCtD
Gadobutrol—Palpitations—Docetaxel—skin cancer	0.00337	0.00337	CcSEcCtD
Gadobutrol—Convulsion—Docetaxel—skin cancer	0.00331	0.00331	CcSEcCtD
Gadobutrol—Nausea—Bleomycin—skin cancer	0.0033	0.0033	CcSEcCtD
Gadobutrol—Vomiting—Dactinomycin—skin cancer	0.00329	0.00329	CcSEcCtD
Gadobutrol—Rash—Dactinomycin—skin cancer	0.00327	0.00327	CcSEcCtD
Gadobutrol—Diarrhoea—Temozolomide—skin cancer	0.0032	0.0032	CcSEcCtD
Gadobutrol—Hypersensitivity—Fluorouracil—skin cancer	0.00318	0.00318	CcSEcCtD
Gadobutrol—Dry mouth—Docetaxel—skin cancer	0.00318	0.00318	CcSEcCtD
Gadobutrol—Anaphylactic shock—Docetaxel—skin cancer	0.00311	0.00311	CcSEcCtD
Gadobutrol—Dizziness—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Gadobutrol—Infection—Docetaxel—skin cancer	0.00309	0.00309	CcSEcCtD
Gadobutrol—Nausea—Dactinomycin—skin cancer	0.00308	0.00308	CcSEcCtD
Gadobutrol—Vomiting—Temozolomide—skin cancer	0.00298	0.00298	CcSEcCtD
Gadobutrol—Rash—Temozolomide—skin cancer	0.00295	0.00295	CcSEcCtD
Gadobutrol—Diarrhoea—Fluorouracil—skin cancer	0.00295	0.00295	CcSEcCtD
Gadobutrol—Dermatitis—Temozolomide—skin cancer	0.00295	0.00295	CcSEcCtD
Gadobutrol—Headache—Temozolomide—skin cancer	0.00293	0.00293	CcSEcCtD
Gadobutrol—Dizziness—Fluorouracil—skin cancer	0.00285	0.00285	CcSEcCtD
Gadobutrol—Insomnia—Docetaxel—skin cancer	0.00282	0.00282	CcSEcCtD
Gadobutrol—Paraesthesia—Docetaxel—skin cancer	0.0028	0.0028	CcSEcCtD
Gadobutrol—Nausea—Temozolomide—skin cancer	0.00278	0.00278	CcSEcCtD
Gadobutrol—Dyspnoea—Docetaxel—skin cancer	0.00278	0.00278	CcSEcCtD
Gadobutrol—Vomiting—Fluorouracil—skin cancer	0.00274	0.00274	CcSEcCtD
Gadobutrol—Rash—Fluorouracil—skin cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Dermatitis—Fluorouracil—skin cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Headache—Fluorouracil—skin cancer	0.0027	0.0027	CcSEcCtD
Gadobutrol—Pain—Docetaxel—skin cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Nausea—Fluorouracil—skin cancer	0.00256	0.00256	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Docetaxel—skin cancer	0.00255	0.00255	CcSEcCtD
Gadobutrol—Abdominal pain—Docetaxel—skin cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Body temperature increased—Docetaxel—skin cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Hypersensitivity—Docetaxel—skin cancer	0.00229	0.00229	CcSEcCtD
Gadobutrol—Diarrhoea—Docetaxel—skin cancer	0.00213	0.00213	CcSEcCtD
Gadobutrol—Dizziness—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Gadobutrol—Vomiting—Docetaxel—skin cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Rash—Docetaxel—skin cancer	0.00196	0.00196	CcSEcCtD
Gadobutrol—Dermatitis—Docetaxel—skin cancer	0.00196	0.00196	CcSEcCtD
Gadobutrol—Headache—Docetaxel—skin cancer	0.00195	0.00195	CcSEcCtD
Gadobutrol—Nausea—Docetaxel—skin cancer	0.00185	0.00185	CcSEcCtD
